Search the Newsreel

StoneX (SNEX) Q3 2026 Earnings Call Transcript

NEXN Stock Price and Chart — NASDAQ:NEXN

This article provides a detailed overview of Nexxen International Ltd. (NEXN) stock, including its current price, market capitalization, financial performance, and analyst ratings. It highlights key statistics such as revenue and EPS, recent earnings reports, and future forecasts, along with a list of ETFs …

NEE Looks 3.1% Overvalued on GF Value™

NextEra Energy Inc (NEE) has secured a major financing agreement with the U.S. Department of Commerce and the Japanese government for a natural gas generation project in Texas and Pennsylvania. Despite a strong GF Score™ of 89/100 and an attractive dividend profile with a …

PropNex H1 net profit down 3.1% at S$40.9 million; interim dividend unchanged

PropNex records 1HFY2026 earnings of $40.9 mil, down 3.1% y-o-y

PropNex records 1HFY2026 earnings of $40.9 mil

Cognex CEO Matthew Moschner Executes Stock Option Exercises and Sells 28,562 Shares Under Rule 10b5-1 Plan

Cognex Corp CEO Matthew Moschner exercised stock options and sold 28,562 shares of common stock on August 11, 2026, under a Rule 10b5-1 trading plan. These transactions resulted in his direct beneficial ownership decreasing to 10,884 shares of Cognex Common Stock. The sales and …

Incannex Healthcare Inc. (IXHL) options chain

This article provides detailed options chain data for Incannex Healthcare Inc. (IXHL), including call options with their last trade dates, strike prices, last prices, bid/ask, change, volume, open interest, and implied volatility. It also shows the current stock price and after-hours trading information for …

Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns

Nexalin Technology (NXL) reported significant losses and limited revenue for the quarter and six months ended June 30, 2026, leading management to conclude there is substantial doubt about its ability to continue as a going concern without additional funding. The company also faces a …

Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary

Nexalin Technology, Inc. reported its Q2 2026 results, showing a significant year-over-year revenue decline to $12.16K and an increased net loss of ($2.24M), resulting in a diluted EPS of ($0.11). The company saw a shift towards higher-margin licensing, improved gross margins, and made clinical …

NextEra Energy secures funding for 10 GW gas projects

NextEra Energy Inc. has announced agreements with the U.S. Department of Commerce and the Government of Japan to fund the development and operation of up to 10 gigawatts of natural gas-powered generation projects in Texas and Pennsylvania. This initiative is part of Japan's $550 …

Annexon (NASDAQ: ANNX) reports $99.5M H1 2026 loss and secures new $200M debt facility

NextEra Energy, U.S. Department of Commerce and Government of Japan finalize commercial terms; reach funding milestone for up to 10 GW of gas-powered generation

JUNO BEACH, Fla., Aug. 12, 2026 /PRNewswire/ -- NextEra Energy, Inc. (NYSE: NEE) today announced it has executed definitive agreements with the U.S. Department of Commerce and the Government of Japan to fund the development and operation of up to 10 gigawatts of natural …

Nexalin Technology | 8-K: Current report

This article is a current report (8-K) filed by Nexalin Technology. It signifies a significant event that the company is required to disclose to the SEC, though the specific details of the event are not provided in this snippet.

Cognex (CGNX) CEO Moschner sells 24,962 shares after exercising options

Cognex (CGNX) CEO & President Matthew Moschner exercised 16,600 stock options and sold 24,962 shares of common stock on August 11, 2026, generating approximately $1.60 million in gross sale proceeds. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan. Despite the sales, …

NextNRG Q2 Results: Conference call scheduled for Aug 13

NextNRG, Inc. (NASDAQ: NXXT) is scheduled to host a conference call on Thursday, August 13, 2026, at 4:30 p.m. Eastern Time. The call will cover the company's second-quarter 2026 financial results and provide a corporate update on its AI-driven energy innovation. Investors can access …

Nexxen International (NASDAQ:NEXN) Price Target Raised to $13.00 at Needham & Company LLC

Needham & Company LLC has increased its price target for Nexxen International (NASDAQ:NEXN) to $13.00 from $10.50, maintaining a "buy" rating and indicating a potential upside of 24.05%. This follows Nexxen exceeding its Q2 earnings and revenue expectations, with the company reporting $0.23 EPS …

NextNav Q2 Earnings Call Highlights

NextNav's Q2 earnings call highlighted strengthened financials, increased liquidity, and advancements in regulatory approval and technological partnerships for its 900 MHz terrestrial positioning, navigation, and timing network. The company became debt-free, increased liquidity to $300 million, and received support from SpaceX in its FCC …

StoneX Group Inc. (SNEX) files 13F showing $2.48B across 1,464 positions

StoneX Group Inc. (SNEX) has filed its quarterly Form 13F report, disclosing equity holdings totaling $2.48 billion across 1,464 positions. The filing, which includes holdings from StoneX Advisors Inc., STONEX FINANCIAL INC., and TRUST ADVISORY GROUP LTD, provides a detailed look into the investment …

Why Cognex Corporation (CGNX) Stock Is Down Today

Why Cognex (CGNX) Shares Are Sliding Today What Happened? Shares of machine vision technology company Cognex (NASDAQ:CGNX) fell 4% in the afternoon session after HSBC downgraded the stock to "Hold" from "Buy" and slashed its price target. The bank adjusted its price target on …

Nexxen International (NASDAQ:NEXN) Issues Quarterly Earnings Results

Why Cognex (CGNX) Shares Are Sliding Today

Why Cognex (CGNX) Shares Are Sliding Today What Happened? Shares of machine vision technology company Cognex (NASDAQ:CGNX) fell 4% in the afternoon session after HSBC downgraded the stock to "Hold" from "Buy" and slashed its price target. The bank adjusted its price target on …

Annexon Releases Q2 2026 Financial Results

Annexon, Inc. (ANNX) reported a Q2 2026 basic and diluted loss per share of $0.28, an improvement from $0.34 in the prior year. The clinical-stage biopharmaceutical company posted a net loss of $55.3 million as it continues to invest in its pipeline for inflammatory-related …

Annexon (NASDAQ:ANNX) Issues Earnings Results, Misses Estimates By $0.05 EPS

Annexon (NASDAQ:ANNX) reported second-quarter earnings, missing analysts' consensus estimates by $0.05 with a loss of $0.28 per share. Despite the earnings miss, the company highlighted positive clinical trial data for tanruprubart in Guillain-Barré syndrome and expanded its ARCHER II geographic atrophy trial. Annexon also …

TD SYNNEX (SNX), What Is Behind The Fresh Attention?

TD SYNNEX (SNX) is gaining attention due to its expanded IBM distribution network across 20 new countries and its positioning in the AI infrastructure market. Despite a recent share price surge, the company is considered undervalued with a fair value of $333.55, primarily driven …

Diginex provides update on proposed Resulticks acquisition

Diginex Limited (NASDAQ:DGNX) announced it is continuing to finalize documentation for its proposed acquisition of Resulticks Global Companies Pte. Limited. Both companies are in the final stages of completing transaction documentation and expect to issue a market update upon formal execution. Diginex noted there's …

Adage Capital files Schedule 13G showing 7.67% NextCure (NXTC) ownership

Adage Capital Management, L.P. and its affiliates have reported a 7.67% passive ownership stake in NextCure, Inc. (NXTC) through a Schedule 13G filing. The investment firm beneficially owns 277,202 shares of NextCure's common stock, based on 3,612,096 shares outstanding as of May 1, 2026. …

NextNRG, Inc. to Host Second Quarter 2026 Earnings Conference Call on August 13

NextNRG, Inc. (NXXT) will host a conference call on August 13, 2026, at 4:30 p.m. Eastern Time to discuss its second-quarter 2026 financial results and provide a corporate update. The company, known for its AI-driven Smart Controller technology in energy management, will offer a …

Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants

Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has reported a beneficial ownership of 1,041,824 shares of SCYNEXIS, Inc. common stock, which includes 498,346 shares issuable upon the exercise of warrants. This stake represents 9.99% of SCYNEXIS's outstanding common stock, calculated …

Diginex Says Resulticks Deal Still Awaits Signed Documents

Diginex (NASDAQ: DGNX) announced that its proposed acquisition of Resulticks Global Companies Pte. Limited is still in the final stages of documentation. The company is actively working to finalize remaining details and expects to issue a further market update upon the formal execution of …

Nexxen International Q2 Earnings Call Highlights

Key Points Interested in Nexxen International Ltd. Sponsored ADR? Here are five stocks we like better. Record Q2 performance: Contribution ex-TAC rose 11% year over year to $97.8 million, while programmatic revenue increased 12% to $95.2 million. CTV revenue jumped 33% to a record …

Nextensa delivers strong half-year results, supported by several successful transactions

Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of …

Simcere Zaiming sells $184,800 of NextCure stock

Simcere Zaiming, Inc. sold 30,000 shares of NextCure, Inc. (NASDAQ:NXTC) common stock for $184,800 on August 10, 2026, leading to their exit as a beneficial owner of more than 10% of NextCure. This transaction occurred as NextCure announced a merger agreement with Avere Therapeutics …

Simcere group (NXTC) trims NextCure stake, ends 10% beneficial ownership

Simcere Zaiming, Inc., and related entities, sold 30,000 shares of NextCure, Inc. common stock at $6.16 per share on August 10, 2026. This transaction reduced their indirect holdings to 308,636 shares. As a result of this sale, the Simcere group is no longer a …

Earnings call transcript: Nexxen lifts 2026 outlook after record Q2 growth

Nexxen International Ltd. reported record second-quarter results with double-digit growth in contribution ex-TAC and programmatic revenue, leading management to raise its full-year 2026 revenue guidance for the third time this year. Despite a slight dip in non-IFRS diluted earnings per share due to increased …

StoneX Group Board Member Makes $161K Stock Purchase

Dhamu R Thamodaran, a Board Member at StoneX Group (NASDAQ: SNEX), purchased 2,500 shares worth $161,206 on August 11, according to an SEC filing. This insider transaction signals confidence in the company, with StoneX Group shares rising by 2.55% to $68.95 following the disclosure. …